Tags : ChulaCov19 Vaccine

News

ChulaCov19 COVID Vaccine as Effective as Pfizer’s

BANGKOK, Aug 16 (TNA) – The ChulaCov19 vaccine proved to be as effective as the Pfizer vaccine when it comes to antibody stimulation to fight COVID-19, according to its developers. King Chulalongkorn Memorial Hospital, the Thai Red Cross Society and the Chula Vaccine Research Center announced the achievement of their ChulaCov19, Thailand’s first mRNA COVID-19 […]Read More

News

Chula Medicine Announced the Success of Clinical Trials for the

August 16, 2021 – Chulalongkorn Memorial Hospital, Thai Red Cross Society, and the Vaccine Research Center, Faculty of Medicine, Chulalongkorn University (CVRC) held a press conference on the progress of clinical trials for the Thai “ChulaCov19” mRNA vaccine.  The clinical trial (Phase 1) was administered in healthy volunteers who are found to have good immunity after […]Read More

News

“ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans

On June 14, 2021 at Bhumisirimangalanusorn Building, Chulalongkorn Memorial Hospital, the Thai Red Cross Society, the Faculty of Medicine and the Chula Vaccine Research Center (CVRC), Faculty of Medicine, Chulalongkorn University conducted its first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health. The process […]Read More

News

Human Trial Starts for ChulaCov19 Vaccine

BANGKOK, June 15 (TNA) – Chulalongkorn University on Monday started the human trial of its ChulaCov19 vaccine after successfully doing it with monkeys and mice. Prof Dr Sutiipong Wacharasindhu, dean of the Faculty of Medicine at Chulalongkorn University, said the first phase of human trial for ChulaCov19 began with volunteers under supervision by many parties […]Read More

News

Chulalongkorn University to Test its COVID-19 Vaccine in Volunteers

BANGKOK, Feb 18 (TNA) – The Faculty of Medicine of Chualongkorn University will test its COVID-19 vaccine in volunteers in either late April or early May after successful trial in monkeys last year. Prof Dr Suttipong Wacharasindhu, director of Chulalongkorn Hospital, said the second jab of the mRNA-typed ChulaCov19 vaccine proved to make monkeys develop […]Read More